Lung cancer remains the leading cause of death from cancer.1 For persons at high risk, low-dose computed topography screening effectively identifies early-stage lung cancer and can reduce lung cancer mortality.2 In 2021, the US Preventive Services Task Force (USPSTF) broadened recommended lung cancer screening (LCS) guidelines to include adults aged 50 to 79 years with a cigarette smoking history of 20 or more years who are current or recent (within 15 years) smokers.3 Studies of LCS prevalence have examined data from either the population who meet all USPSTF criteria4 or selected LCS registries.5 In other contexts, such as breast cancer, screening outside USPSTF recommendations is common, and those choosing screening outside recommendations are often at considerably higher risk.6 Using nationally representative data, we investigated the prevalence of LCS by eligibility with respect to USPSTF criteria, and we compared those choosing screening by eligibility.

Darden, M. E., & Hoagland, A. (2025). Lung Cancer Screening and USPSTF Recommendations. JAMA Network Open8(2), e2458916-e2458916.